Gastrointestinal Stromal Tumor (GIST) Market is driven by Precision...

a adăugat un sunet Health

2025-05-26 10:15:30 -

Gastrointestinal Stromal Tumor (GIST) Market is driven by Precision Medicine

The gastrointestinal stromal tumor (GIST) market encompasses innovative targeted therapies, including tyrosine kinase inhibitors (TKIs) such as imatinib, sunitinib, regorafenib, ripretinib, and avapritinib. These products offer significant advantages over traditional chemotherapy by blocking specific oncogenic pathways, reducing off-target toxicity, and improving patient outcomes....

0 Commentarii 0 Distribuiri 499 Views 0 previzualizare